Why the study?
Do clinicopathologic and molecular features differ between sporadic and radiation-associated angiosarcomas?
Do clinicopathologic and molecular features differ between sporadic and radiation-associated angiosarcomas?
Sporadic and radiation-associated angiosarcomas share similar histologic, immunohistochemical, and molecular profiles, as well as overall prognosis.
No takes yet. Share an insight, caveat, or question.
Supports similar management of SA and RAA given comparable survival and profiles; leaves open prospective validation of unified therapeutic strategies.
Hung et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: